140 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
101 | 16518417 | Dicoumarol potentiates cisplatin-induced apoptosis mediated by c-Jun N-terminal kinase in p53 wild-type urogenital cancer cell lines. | 2006 Apr 20 | 3 |
102 | 16529740 | Two distinct steps of Bak regulation during apoptotic stress signaling: different roles of MEKK1 and JNK1. | 2006 May 15 | 1 |
103 | 16596182 | Cellular components involved in the cell death induced by cisplatin in the absence of p53 activation. | 2006 May | 2 |
104 | 16619517 | C-jun N-terminal kinase activation is required for apoptotic cell death induced by TNF-related apoptosis-inducing ligand plus DNA-damaging agents in sarcoma cell lines. | 2006 Mar-Apr | 5 |
105 | 16951204 | Mitogen-activated protein kinase phosphatase-1 is required for cisplatin resistance. | 2006 Sep 1 | 2 |
106 | 16984892 | c-Jun NH2-terminal kinase promotes apoptosis by down-regulating the transcriptional co-repressor CtBP. | 2006 Nov 17 | 1 |
107 | 15841377 | Human cells deficient in transcription-coupled repair show prolonged activation of the Jun N-terminal kinase and increased sensitivity following cisplatin treatment. | 2005 Aug | 4 |
108 | 16038800 | Conditional expression of MAP kinase phosphatase-2 protects against genotoxic stress-induced apoptosis by binding and selective dephosphorylation of nuclear activated c-jun N-terminal kinase. | 2005 Oct | 2 |
109 | 16082193 | Molecular pathways in the chemosensitization of cisplatin by quercetin in human head and neck cancer. | 2005 Sep | 1 |
110 | 16105650 | Reversing chemoresistance in cisplatin-resistant human ovarian cancer cells: a role of c-Jun NH2-terminal kinase 1. | 2005 Oct 7 | 13 |
111 | 16238095 | Role of the phosphatase PP4 in the activation of JNK-1 in prostate carcinoma cell lines PC-3 and LNCaP resulting in increased AP-1 and EGR-1 activity. | 2005 | 1 |
112 | 16357177 | Bortezomib sensitizes pancreatic cancer cells to endoplasmic reticulum stress-mediated apoptosis. | 2005 Dec 15 | 1 |
113 | 14722256 | Quantitative effects on c-Jun N-terminal protein kinase signaling determine synergistic interaction of cisplatin and 17-allylamino-17-demethoxygeldanamycin in colon cancer cell lines. | 2004 Jan | 4 |
114 | 15001534 | Phosphorylation of FADD is critical for sensitivity to anticancer drug-induced apoptosis. | 2004 Jul | 1 |
115 | 15254743 | Mechanisms underlying the synergistic effect of SU5416 and cisplatin on cytotoxicity in human ovarian tumor cells. | 2004 Aug | 1 |
116 | 15386344 | Long-term activation of SAPK/JNK, p38 kinase and fas-L expression by cisplatin is attenuated in human carcinoma cells that acquired drug resistance. | 2004 Dec 20 | 9 |
117 | 15604295 | Caspase inhibitors, but not c-Jun NH2-terminal kinase inhibitor treatment, prevent cisplatin-induced hearing loss. | 2004 Dec 15 | 1 |
118 | 12637505 | Sustained activation of JNK/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells. | 2003 May 23 | 12 |
119 | 12663670 | The activation of c-Jun NH2-terminal kinase (JNK) by DNA-damaging agents serves to promote drug resistance via activating transcription factor 2 (ATF2)-dependent enhanced DNA repair. | 2003 Jun 6 | 1 |
120 | 12697749 | AKT2 inhibition of cisplatin-induced JNK/p38 and Bax activation by phosphorylation of ASK1: implication of AKT2 in chemoresistance. | 2003 Jun 27 | 4 |
121 | 14520687 | Inhibition of JNK signaling diminishes early but not late cellular stress-induced apoptosis. | 2003 Nov 20 | 1 |
122 | 12018840 | Signaling and function of caspase and c-jun N-terminal kinase in cisplatin-induced apoptosis. | 2002 Apr 30 | 5 |
123 | 12149148 | An anti-GD2 monoclonal antibody enhances apoptotic effects of anti-cancer drugs against small cell lung cancer cells via JNK (c-Jun terminal kinase) activation. | 2002 Jul | 3 |
124 | 12181446 | Regulation of platinum-compound cytotoxicity by the c-Jun N-terminal kinase and c-Jun signaling pathway in small-cell lung cancer cells. | 2002 Sep | 5 |
125 | 11340162 | Cisplatin induces the proapoptotic conformation of Bak in a deltaMEKK1-dependent manner. | 2001 Jun | 1 |
126 | 11396136 | Analysis of cellular sensitization with cisplatin-induced apoptosis by glucose-starved stress in cisplatin-sensitive and -resistant A431 cell line. | 2001 Mar-Apr | 1 |
127 | 11592233 | Nicotine affects the signaling of the death pathway, reducing the response of head and neck cancer cell lines to DNA damaging agents. | 2001 Oct | 1 |
128 | 30147474 | Activation of the JNK/SAPK and P38 Mitogen-Activated Protein Kinase Signaling Pathways Sensitize Tumor Cells to Cisplatin-Induced Apoptosis. | 2001 | 1 |
129 | 10639576 | Cisplatin-resistance involves the defective processing of MEKK1 in human ovarian adenocarcinoma 2008/C13 cells. | 2000 Feb | 1 |
130 | 11064451 | CL100/MKP-1 modulates JNK activation and apoptosis in response to cisplatin. | 2000 Oct 26 | 4 |
131 | 11170260 | Cisplatin-induced response of c-jun N-terminal kinase 1 and extracellular signal--regulated protein kinases 1 and 2 in a series of cisplatin-resistant ovarian carcinoma cell lines. | 2000 Dec | 17 |
132 | 9926932 | ASK1 mediates apoptotic cell death induced by genotoxic stress. | 1999 Jan 7 | 2 |
133 | 10098743 | Induction of JNK and c-Abl signalling by cisplatin and oxaliplatin in mismatch repair-proficient and -deficient cells. | 1999 Mar | 6 |
134 | 10353733 | Cisplatin-induced activation of mitogen-activated protein kinases in ovarian carcinoma cells: inhibition of extracellular signal-regulated kinase activity increases sensitivity to cisplatin. | 1999 May | 4 |
135 | 10531373 | Inhibition of extracellular signal-regulated protein kinase or c-Jun N-terminal protein kinase cascade, differentially activated by cisplatin, sensitizes human ovarian cancer cell line. | 1999 Oct 29 | 6 |
136 | 9484843 | Cisplatin induces a persistent activation of JNK that is related to cell death. | 1998 Jan 29 | 3 |
137 | 10081494 | EAT/mcl-1, a member of the bcl-2 related genes, confers resistance to apoptosis induced by cis-diammine dichloroplatinum (II) via a p53-independent pathway. | 1998 Dec | 2 |
138 | 9162025 | The Jun kinase/stress-activated protein kinase pathway functions to regulate DNA repair and inhibition of the pathway sensitizes tumor cells to cisplatin. | 1997 May 30 | 4 |
139 | 9242457 | Differential induction of c-Jun NH2-terminal kinase and c-Abl kinase in DNA mismatch repair-proficient and -deficient cells exposed to cisplatin. | 1997 Aug 1 | 6 |
140 | 9252645 | The Ras farnesylation inhibitor BZA-5B increases the resistance to cisplatin in a human melanoma cell line. | 1997 Jul-Aug | 2 |